Our findings revealed that the ENOSF1 rs2612091-TT genotype and the TYMS/ENOSF1 ACT haplotype were associated with longer DFS in CRC patients undergoing adjuvant capecitabine-based therapy. The gene discussed is ENOSF1; the disease is colorectal carcinoma.